Method for treatment of essential (hemorrhagic) thrombocythemia

Details Method for treatment of essential (hemorrhagic) thrombocythemia Method for treatment of essential (hemorrhagic) thrombocythemia

1985-07-25

1988-05-10

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Lymphokine

435811, A61K 4502

Patent

active

047434457

ABSTRACT:
A method for the treatment of essential thrombocythemia, said method comprising the administration of alpha-type interferons in an amount and for a period of time sufficient to reduce the platelet count to physiologically acceptable levels.

REFERENCES:
Chemical Abstracts, vol. 102, p. 469, Abstract No. 219435d, 1985.
Urushiyami et al.; Igaku no Ayumi 131(11/12): 739-740 (1984).
Talpaz et al., Ann. Int. Med. 99: 787-792 (1983).
Cantell et al., J. gen. Virol. 39:541-543 (1978).
Zor et al., J. gen. Virol. 63:359-363 (1982).
Baracos et al., N. Eng. J. Med., vol. 308: No. 10, pp. 553-558 (1983).
Harrison's Principles of Internal Medicine, McGraw-Hill, N.Y., p. 1898 (1983).
Velu et al., Blood 64(5), Supp. 1, 176a Abstract No. 6116 (Nov. 1984).

Affiliated with

Also associated with

Rating

Method for treatment of essential (hemorrhagic) thrombocythemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of essential (hemorrhagic) thrombocythemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of essential (hemorrhagic) thrombocythemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1319749